A validated liquid chromatography-mass spectrometry method for the determination of leukotrienes B4 and B5 produced by stimulated human polymorphonuclear leukocytes

Analytical Biochemistry

Volumn 341, Issue 1, 2005, Pages 58-68

  Panchaud, A ^a   Avois, L ^b   Roulet, M ^a   Pilet, M ^a   Hug, C ^a   Saugy, M ^b   Decosterd, L A ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY CENTER OF LEGAL MEDICINE   (Switzerland)

Author keywords

HPLC MS; LTB4; LTB5; Omega 3; Polymorphonuclear leukocytes; Validation

Indexed keywords

ELECTROSPRAY IONIZATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; POLYUNSATURATED FATTY ACIDS;

HPLC-MS; LTB4; LTB5; OMEGA-3; POLYMORPHONUCLEAR LEUKOCYTES; VALIDATION;

DRUG PRODUCTS;

AMMONIUM ACETATE; LEUKOTRIENE B4; LEUKOTRIENE B5; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PROSTAGLANDIN B2;

ACCURACY; ARTICLE; CALIBRATION; CELL STIMULATION; CONTROLLED STUDY; CYSTIC FIBROSIS; DIETARY INTAKE; ELUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; ION MONITORING; NEUTROPHIL; PRIORITY JOURNAL; QUADRUPOLE MASS SPECTROMETRY; QUANTITATIVE ANALYSIS; SEPARATION TECHNIQUE; VALIDATION PROCESS;

EID: 18144396888     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ab.2005.02.030     Document Type: Article

References (43)

1. A.W. Ford-Hutchinson, M. Gresser, and R.N. Young 5-Lipoxygenase Annu. Rev. Biochem. 63 1994 383 417
2. C. Brink, S.E. Dahlen, J. Drazen, J.F. Evans, and D.W. Hay International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors Pharmacol. Rev. 55 2003 195 227
3. P. Borgeat, and P.H. Naccache Biosynthesis and biological activity of leukotriene B4 Clin. Biochem. 23 1990 459 468
4. B. Samuelsson, S.E. Dahlen, J.A. Lindgren, C.A. Rouzer, and C.N. Serhan Leukotrienes and lipoxins: structures, biosynthesis, and biological effects Science 237 1987 1171 1176
5. S. Kannan Amplification of extracellular nucleotide-induced leukocyte(s) degranulation by contingent autocrine and paracrine mode of leukotriene-mediated chemokine receptor activation Med. Hypoth. 59 2002 261 265
6. W.W. Busse Leukotrienes and inflammation Am. J. Respir. Crit. Care Med. 157 1998 S210 S213 discussion S247-218
7. A.W. Ford-Hutchinson Leukotriene B4 in inflammation Crit. Rev. Immunol. 10 1990 1 12
8. P.M. O'Byrne Why does airway inflammation persist? Is it leukotrienes? Am. J. Respir. Crit. Care Med. 161 2000 S186 S187
9. S.W. Crooks, and R.A. Stockley Leukotriene B4 Int. J. Biochem. Cell Biol. 30 1998 173 178
10. R.A. Lewis, K.F. Austen, and R.J. Soberman Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases N. Engl. J. Med. 323 1990 645 655
11. C. von Schacky, C. Fahrer, and S. Fischer Catabolism of leukotriene B5 in humans J. Lipid Res. 31 1990 1831 1838
12. M. Koller, M. Senkal, M. Kemen, W. Konig, V. Zumtobel, and G. Muhr Impact of omega-3 fatty acid enriched TPN on leukotriene synthesis by leukocytes after major surgery Clin. Nutr. 22 2003 59 64
13. A. Seya, T. Terano, Y. Tamura, and S. Yoshida Comparative effect of leukotriene B4 and leukotriene B5 on calcium mobilization in human neutrophils Prostaglandins Leukot. Essent. Fatty Acids 34 1988 47 50
14. T.H. Lee, T. Sethi, A.E. Crea, W. Peters, and J.P. Arm Characterization of leukotriene B3: comparison of its biological activities with leukotriene B4 and leukotriene B5 in complement receptor enhancement, lysozyme release and chemotaxis of human neutrophils Clin. Sci. 74 1988 467 475
15. T.H. Lee, J.M. Menica-Huerta, C. Shih, E.J. Corey, R.A. Lewis, and K.F. Austen Characterization and biologic properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotriene B5 and the double lipoxygenase product J. Biol. Chem. 259 1984 2383 2389
16. J. Dyerberg, H.O. Bang, E. Stoffersen, S. Moncada, and J.R. Vane Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 2 1978 117 119
17. J. Dyerberg, and H.O. Bang Haemostatic function and platelet polyunsaturated fatty acids in Eskimos Lancet 2 1979 433 435
18. P.C. Calder n-3 polyunsaturated fatty acids and cytokine production in health and disease Ann. Nutr. Metab. 41 1997 203 234
19. S. Endres, R. De Caterina, E.B. Schmidt, and S.D. Kristensen n-3 polyunsaturated fatty acids: update 1995 Eur. J. Clin. Invest. 25 1995 629 638
20. E.A. Miles, and P.C. Calder Modulation of immune function by dietary fatty acids Proc. Nutr. Soc. 57 1998 277 292
21. T. Obata, T. Nagakura, T. Masaki, K. Maekawa, and K. Yamashita Eicosapentaenoic acid inhibits prostaglandin D2 generation by inhibiting cyclo-oxygenase-2 in cultured human mast cells Clin. Exp. Allergy 29 1999 1129 1135
22. T.H. Lee, R.L. Hoover, J.D. Williams, R.I. Sperling, and J. Ravalese III Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function N. Engl. J. Med. 312 1985 1217 1224
23. R.I. Sperling, A.I. Benincaso, C.T. Knoell, J.K. Larkin, K.F. Austen, and D.R. Robinson Dietary omega-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils J. Clin. Invest. 91 1993 651 660
24. P.C. Calder N-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic Lipids 38 2003 343 352
25. P. Borgeat, and B. Samuelsson Arachidonic acid metabolism in polymorphonuclear leukocytes: unstable intermediate in formation of dihydroxy acids Proc. Natl. Acad. Sci. USA 76 1979 3213 3217
26. F. Grimminger, C. Scholz, S. Bhakdi, and W. Seeger Subhemolytic doses of Escherichia coli hemolysin evoke large quantities of lipoxygenase products in human neutrophils J. Biol. Chem. 266 1991 14262 14269
27. N. Saku, J. Kobayashi, and S. Kitamura Eicosapentaenoic acid modulates arachidonic acid metabolism in rat alveolar macrophages activated by silica Prostaglandins Leukot. Essent. Fatty Acids 61 1999 51 54
28. M. Takamoto, T. Yano, T. Shintani, and S. Hiraku A highly sensitive and selective method for the determination of Leukotriene B4 in human plasma by negative ion chemical ionization/gas chromatography/tandem mass spectrometry J. Pharm. Biomed. Anal. 13 1995 1465 1472
29. M. Kumlin Analytical methods for the measurement of leukotrienes and other eicosanoids in biological samples from asthmatic subjects J. Chromatogr. A 725 1996 29 40
30. P. Montuschi, S. Martello, M. Felli, C. Mondino, and M. Chiarotti Ion trap liquid chromatography/tandem mass spectrometry analysis of leukotriene B4 in exhaled breath condensate Rapid Commun. Mass Spectrom. 18 2004 2723 2729
31. P. Wheelan, and R.C. Murphy Quantitation of 5-lipoxygenase products by electrospray mass spectrometry: effect of ethanol on zymosan-stimulated production of 5-lipoxygenase products by human neutrophils Anal. Biochem. 244 1997 110 115
32. Y.Y. William, J. Griffiths, J. Sjövall, and J.Å. Lindgren Electrospray/collision-induced dissociation mass spectrometry of mono-, di and tri- hydroxylated lipoxygenase products, including leukotrienes of the B-series and lipoxins Rapid Commun. Mass Spectrom. 10 1999 183 196
33. C. Heierli, M. Markert, P.H. Lambert, T. Kuwahara, and J.P. Wauters On the mechanisms of haemodialysis-induced neutropenia: a study with five new and re-used membranes Nephrol. Dial. Transplant. 3 1988 773 783
34. B.D. Levy, K. Gronert, C.B. Clish, C.N. Serhan, Lipid second messengers, CRC Press LLC ed, 1999, pp. 84-103
35. V.P. Shah, K.K. Midha, S. Dighe, I.J. McGilveray, and J.P. Skelly Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Conference report Eur. J. Drug Metab. Pharmacokinet. 16 1991 249 255
36. V.P. Shah, K.K. Midha, J.W. Findlay, H.M. Hill, and J.D. Hulse Bioanalytical method validation-a revisit with a decade of progress Pharm. Res. 17 2000 1551 1557
37. P.C.B. Boulanger, P. Chiap, N. Cohen, P.A Compagnon, W. Dewe, M. Feinberg, M. Lallier, M. Laurentie, N. Mercier, G. Muzard, C. Nivet, L. Valat, STP Pharma Pratiques 13 (2003)
38. Draft Guidance for Industry: Analytical Procedures and Methods Validation-Chemistry, Manufacturing, and Controls Documentation, FDA, 2000
39. M. Feinberg Validation des méthodes d'analyse 2004 Dunod Paris
40. G. Hansson, J.A. Lindgren, S.E. Dahlen, P. Hedqvist, and B. Samuelsson Identification and biological activity of novel omega-oxidized metabolites of leukotriene B4 from human leukocytes FEBS Lett. 130 1981 107 112
41. W. Jubiz, O. Radmark, C. Malmsten, G. Hansson, and J.A. Lindgren A novel leukotriene produced by stimulation of leukocytes with formylmethionylleucylphenylalanine J. Biol. Chem. 257 1982 6106 6110
42. S. Shak, and I.M. Goldstein Omega-oxidation is the major pathway for the catabolism of leukotriene B4 in human polymorphonuclear leukocytes J. Biol. Chem. 259 1984 10181 10187
43. C. von Schacky, R. Kiefl, A.J. Marcus, M.J. Broekman, and W.E. Kaminski Dietary n-3 fatty acids accelerate catabolism of leukotriene B4 in human granulocytes Biochim. Biophys. Acta 1166 1993 20 24